IQVIA Investing Cash Flow increased by 82.2% to -$196.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 35.7%, from -$305.00M to -$196.00M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows relatively stable performance with a 2.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$185.00M | -$1.10B | -$647.00M | -$613.00M | -$199.00M | -$717.00M | -$477.00M | -$222.00M | -$596.00M | -$573.00M | -$212.00M | -$314.00M | -$221.00M | -$599.00M | -$310.00M | -$305.00M | -$346.00M | -$550.00M | -$1.10B | -$196.00M |
| QoQ Change | — | -491.9% | +40.9% | +5.3% | +67.5% | -260.3% | +33.5% | +53.5% | -168.5% | +3.9% | +63.0% | -48.1% | +29.6% | -171.0% | +48.2% | +1.6% | -13.4% | -59.0% | -100.7% | +82.2% |
| YoY Change | — | — | — | — | -7.6% | +34.5% | +26.3% | +63.8% | -199.5% | +20.1% | +55.6% | -41.4% | +62.9% | -4.5% | -46.2% | +2.9% | -56.6% | +8.2% | -256.1% | +35.7% |